Tag Archives: cell therapy

Hot Investor Mandate 1: Subsidiary of Large USA and China-Based Biotech Seeks Investment and In-Licensing Opportunities in Cell & Gene Therapies, Invests Up to $10M

19 Apr

An emerging company with China headquarters is focusing on the development of the best-in-class immunotherapy technology for cancer cure. Teamed up with outstanding immunologists and molecular biologists, the firm has generated a strong pipeline of Chimeric Antigen Receptor (CAR) product candidates to treat a wide variety of liquid and solid tumors. The firm is a subsidiary company of another established public biotech company with offices in USA and China. The firm is actively seeking investment, partnering and licensing opportunities to expand the pipeline of therapeutics and offerings. Typical allocations are $1-10 M.

The firm’s sectors of focus are cell and gene therapies, cell engineering, processing and manufacturing technologies and tools.

The firm may seek a board seat depending upon size of investment. They are open to working with all stages of management teams. The firm can either lead or co-invest.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Hot Investor Mandate 4: USA and China-Based Biotech Company Seeks to Invest in Life Science Companies, with Focus on Cell/Gene Therapies, Antibodies, Synthetic Biology, etc.

5 Apr

A public biotech company with headquarters in USA and China is actively seeking for investment, partnering and acquisition opportunities to expand the company’s business in multiple areas. The firm usually invests as a strategic investor in as early as seed rounds. Typical allocations are $1-5 M.

The firm’s sectors of focus are cell and gene therapies, antibody therapeutics, life science tools, drug discovery technologies, synthetic biology technologies and industrial enzyme products.

The firm may seek a board seat depending upon size of investment. The firm is open to working with all stages of management teams and may lead or co-invest.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

<span>%d</span> bloggers like this: